Immunohistochemical localisation of tenascin in invasive ductal carcinoma of the breast

Anticancer Research

Volumn 19, Issue 1 A, 1999, Pages 175-179

  Tökés, Anna Mária ^a   Hortoványi, Eszter ^a   Csordás, György ^a   Kulka, Janina ^a   Mózes, Géza ^a   Hatalyák, Ádám ^a   Kádár, Anna ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Immunohistochemistry; Invasive ductal breast carcinoma; Tenascin

Indexed keywords

ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROTEIN P53; TENASCIN;

ADULT; AGED; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER CELL; CANCER GRADING; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; RECEPTORS, ESTROGEN; TENASCIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0344609222     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Chiquet ER, Mackie EJ, Pearson CA, Sakakura T: Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 47: 131-139, 1986.
2. Chiquet ER, Hagios C, Schenk S: The complexity in regulating the expression of tenascins BioEssays 17 (10): 873-878, 1995.
3. Chiquet ER, Kalla P, Pearson CA: Participation of tenascin and transforming growth factor-β in reciprocal epithelial-mesenchymal interactions of MCF7 cells and fibroblasts. Canc Res 49: 4322-4325, 1989.
4. Csordas Gy, Hatalyák A, Tökés A, Kádár A: Tenascin immunoreactivity differs in tonsil and breast with respect to antibody used. Path Intern 46 Suppl. 1, 1996.
5. Doi D, Araki T, Asano G: Immunohistochemical localization of tenascin, estrogen receptor and transforming growht factor-betal in human endometrial carcinoma. Gynecol-Obstet Invest 41(1): 61-6, 1996.
6. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long term follow up. Histopathol 19: 403-410, 1991.
7. Fresno M, Molina R, Perez RMT, Alvarez S, Diaz LJM, Garcia I, Herrero A: p53 expression is of independent predictive value in lymph node-negative breast carcinoma. Eur J Cancer 33 (8): 1268-74, 1997.
8. Gundersen S, Bohler P, Hannisdal E, Host H: Tumour size and histological grading of stage 1 breast cancer. Prognostic and therapeutic significance. Tidsskr Nor Laegeforen 116(2): 222-225, 1996.
9. Iskaros BF, Tanaka KE, Hu X, Kadish AS, Steinberg JJ: Morphologic pattern of tenascin as a diagnostic biomarker in colon cancer. J Surg Oncol 64 (2): 98-101, 1997.
10. Jahkola T, Terttu T, Smitten K, Blomqvist C, Virtanen I: Expression of tenascin in invasion border of early breast cancer correlates with higher risk of distant metastasis. Int J Cancer 69: 445-447, 1996.
11. Kawakatsu H, Shiurba R, Obara M, Hiraiwa H, Kusakabe M, Sakakura T: Human carcinoma cells synthesize and secrete tenascin In vitro. Jpn. J. Cancer Res. 83: 1073-1080, 1992.
12. Koukoulis GK, Gould Ve, Bhattacharya A, Gould JE, Howeedy AA, Virtanen I: Tenascin in normal, reactive, hyperplastic and neoplastic tissue. Biologic and pathologic implication. Human Pathol 22: 636-643, 1991.
13. Leong ASY, Lee AKC: Biological indices in the assassement of breast cancer. J Clin Pathol: Mol Pathol 48: 221-238, 1995.
14. Mackie EJ, Chiquet ER, Pearson CA, Inaguma Y, Taya K, Kawarada Y, Takakura T: Tenascin is a stromal marker for epithelial malignancy in the mammary gland. Pro Nat Acad Sci 84: 4621-4625, 1987.
15. Moroz K, Lipscomb J, Vial LJ, Dhurandhar N: Cytologic nuclear grade of malignant breast aspirates as a predictor of histologic grade. Light microscopy and image analysis characteristics. Acta Cytol 41(4): 1107-1111, 1997.
16. Natali PG, Nicotra MR, Bigotti A, Botti C, Castellani P, Risso AM7 Zardi L: Comparative analysis of the expression of the extracellular matrix protein tenascin in normal human fetal adult and tumour tissue. Int J Cancer 47: 811-816, 1991.
17. Ostrowski ML, Chakraborty S, Laucirica R, Brown R, Greenberg SD: Qantitative image analysis of MIB-1 immunoreactivity. A comparison with flow cytometric assessment of proliferative activity in invasive carcinoma of the breast. Anal Quant Cytol Histol 17(1): 15-24, 1995.
18. Robinson IA, McKee G, Nicholson A, D' Arcy J, Jackson PA, Cook MG, Kissin MW: Prognostic value of cytological grading of fine-needle aspiration from breast carcinomas. Lancet 343(8903): 947-9, 1994.
19. Spring J, Beck K, Chiquet ER: Two contrary functions of tenascin: dissection of the active sites by recombinant tenascin fragments. Cell 59: 325-334, 1989.
20. Shoji T, Kamiya T, Tsubura A, Hatano T, Sakakura T, Yamamoto M, Morii S: Immunohistochemical staining patterns of tenascin in invasive breast carcinomas. Virchows Archiv A Pathol Anat 421: 53-56, 1992.
21. Tremble P, Chiquet ER, Werb Z: The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. Mol Biol of Cell 5: 439-453, 1994.
22. Vaidya P, Yosida T, Sakakura T, Yatami R, Noguchi T, Kawarada Y: Combined analysis of expression of c-erbB-2, Ki-67 antigen, and tenascin provides a better prognostic indicator of carcinoma ofthe papilla of Vater. Pancreas 12(2): 196-201, 1996.
23. Walker RA, Dearing SJ, Lane DP, Varley JM: Expression of p53 protein in infiltrating and in-situ breast carcinomas. J Pathol 165: 203-211, 1991.
24. Weaver VM, Fischer AH, Peterson OW, Bissell MJ: The importance of the microenvironment in breast cancer progression: recapitulation of mammary tumourigenesis using a unique human mammary epithelial cell model and a three dimensional culture assay. Biochem Cell Biol 74(6): 833-51, 1996.
25. Weidner N, Moore DH, Vartanian R: Correlation of Ki-67 antigen expression with mitotic figure index and tumour grade in breast carcinomas using the novel "paraffin"-reactive MIB1 antibody. Hum Pathol 25: 337-342, 1994.
26. Yoshida T, Ishihara A, Hirokawa Y, Kusakabe M, Sakakura T: (1995) Tenascin in breast cancer development - is epithelial tenascin a marker for poor prognosis? Cancer Lett 90 (1): 65-73, 1995.